ClinicalTrials.gg
RecruitingNCT07433153Updated Aug 25, 2026

Comparison of Smartphone and Community-Based Delivery of the Otago Exercise Program for Fall Risk in Older Adults

An interventional study of Smartphone-Based Intervention and Group-Based Intervention in Frail Elderly and Fall, sponsored by Binghamton University. Recruiting at 1 site in United States. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Binghamton University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
55 Years and older
Sex
All
01

Study summary

The long-term goal of this project is to effectively bridge the research-clinic-community gap and to foster partnerships that support the implementation, utilization, and advocacy of evidence-based fall prevention programs in the older adult community. The Otago Exercise Program (OEP) is an evidence-based fall prevention program that has been shown to reduce falls and fall-related injuries among older adults. Traditionally, OEP is delivered in the home by a physical therapist and focuses on muscle strengthening and balance training. Despite its proven effectiveness, adherence and compliance rates have been low. The personnel and resource demands of program delivery, along with challenges in monitoring participant adherence, represent significant barriers to broader implementation. Alternative delivery systems using remote and community-based platforms may help address these limitations.

Specific Aim 1: To compare the effectiveness of two delivery modes of the Otago Exercise Program: a remotely delivered, home-based smartphone program and an in-person, community-based program.

Specific Aim 2: To examine the feasibility, acceptability, and usability of the Otago Exercise Program delivered through both smartphone-based and in-person formats.

Read the detailed description

Thirty eligible participants will provide written informed consent prior to enrollment. In accordance with the World Guidelines for Falls Prevention, participants will be stratified into low-, intermediate-, and high-risk groups. Following the first visit assessment, older adults classified as intermediate or high risk will be randomly assigned to one of two intervention groups: (1) a remotely delivered, smartphone- based Otago Exercise Program, or (2) an in-person, community-based Otago Exercise Program.

Participants in both groups will receive individualized 60-minute training sessions, two times per week for eight weeks. Across the sixteen training sessions, participants will receive a progressive balance, mobility, and strengthening program following the structure of the Otago Exercise Program.

Prior to and immediately following the exercise program, participants are asked to complete several surveys and evaluations, including: demographics, STEADI-12, SF-36, Geriatric Depression Scale (GDS), Falls Efficacy Scale-International (FES-I), Four-Square Stepping Test, Timed Up and Go Test (TUG), Ten-meter Walk Test, Four-Stage Balance Test, 30-second chair stand, and the Physiological Profile Assessment (PPA). All outcome measures will be collected at baseline and at the end of the intervention, with testers blinded to participant group allocation, and trainers blinded to baseline outcomes. In addition, gait speed will be assessed weekly using smartphone-based measurements.

02

Conditions studied

  • Frail Elderly
  • Fall

Keywords

  • Otago
  • Falls
  • Smartphone
  • Group Exercise
  • Balance
  • Stepping
03

In context

Gait Disorders, Neurologic

346 studies on the registry are indexed under Gait Disorders, Neurologic; 54 are open to participants now.

This study's planned enrollment of 36 is above the median of 30 across 261 interventional studies indexed under Gait Disorders, Neurologic.

Browse Gait Disorders, Neurologic studies →

Lead sponsor

Binghamton University is the lead sponsor of 12 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Community-dwelling older adults 55 years of age or older
  • Communicate in English
  • Able to ambulate at least 10 meters with or without an assistive device.
  • Cognitively intact based on scoring 18/22 or greater on the (MoCA)-Blind during a phone screening process
  • Have access to an Android or iOS smartphone
  • Intermediate or high risk of falling, based on World Guidelines for Falls Prevention (Montero-Odasso et al, 2022)

Exclusion criteria

Exclusion Criteria:

  • Lower limb amputation
  • Visual impairment uncorrectable with lenses
  • Uncontrolled hypertension, diabetes, neurological or musculoskeletal impairment
  • Persistent symptoms of dizziness or lightheadedness
  • Spine or lower-extremity surgery in the past 12 months
  • Self-reported pain of >7 on a scale of 0-10
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Smartphone In-home Delivery

    In-home 8-week OTAGO program

    Behavioral: Smartphone-Based Intervention

  • Active comparator
    Group In-Person Delivery

    In-Person 8-week Group OTAGO Program

    Behavioral: Group-Based Intervention

Interventions

  • BehavioralSmartphone-Based Intervention

    Participants in the smartphone-based group will receive Otago Exercise Program instructions delivered through Improve, an investigator-developed application. This application, installed on each participant's iOS or Android smartphone, will allow participants to track their exercises and review workout instructions. Participants in the smartphone-based group will be contacted weekly by phone to ensure safety and adherence and to assist with troubleshooting any technology-related issues. All participants will be instructed to maintain their usual activity patterns and to refrain from initiating any new structured physical activity programs during the 8-week study period. Participants will be directed by Doctor of Physical Therapy students under the supervision of a licensed Physical Therapist, with weekly phone check-ins.

    Also known as: Otago

  • BehavioralGroup-Based Intervention

    Participants in the in-person, community-based group will complete the individualized Otago Exercise Program in a group setting at the Johnson City Senior Center, under the guidance of Doctor of Physical Therapy students (4) and supervision of licensed Physical Therapists.

    Also known as: Otago

06

What researchers measure

Primary outcomes

  1. Gait Velocity

    Self-selected walking speed (m/s) over level surface

    Time frame: Baseline (Day 0) and 1 week post-training (9 weeks later)

Secondary outcomes

  1. Injurious Falls

    Self-reported falls that lead to injury requiring clinical evaluation

    Time frame: Up to 1-year post intervention

  2. PPA-Short Form: Postural Sway

    Sway Area (units: mm\^2) while standing quietly for 30 seconds

    Time frame: Baseline (Day 0) and 1 week post-training (9 weeks later)

  3. PPA-Short Form: Finger Reaction Time

    Simple reaction time (units: msec)

    Time frame: Baseline (Day 0) and 1 week post-training (9 weeks later)

  4. PPA-Short Form: Knee Extensor Strength

    Maximum isometric knee extensor force (kg)

    Time frame: Baseline (Day 0) and 1 week post-training (9 weeks later)

  5. PPA-Short Form: Visual Contrast Sensitivity

    Melbourne Contrast Sensitivity (db), on a scale of 0-24

    Time frame: Baseline (Day 0) and 1 week post-training (9 weeks later)

  6. PPA-Short Form: Proprioception

    Degrees offset in foot positioning

    Time frame: Baseline (Day 0) and 1 week post-training (9 weeks later)

  7. 30-second Chair Stand

    Number of chair rises in 30-seconds

    Time frame: Baseline (Day 0) and 1 week post-training (9 weeks later)

  8. TUG

    Timed up and go test. Rise from a chair, walk 3-meters, turn, and return walk, and sit back down at self-selected speed

    Time frame: Baseline (Day 0) and 1 week post-training (9 weeks later)

  9. Four-Stage Balance

    Total time to stand in side-to-side, semi-tandem, tandem, one-leg stance.

    Time frame: Baseline (Day 0) and 1 week post-training (9 weeks later)

  10. Smartphone-based assessments

    Self-evaluated walking speed as performed by participants at home

    Time frame: Weekly during 8-week training program

Other outcomes

  1. Four square step test

    Time to complete a clockwise and counterclockwise stepping into four quadrants

    Time frame: Baseline (Day 0) and 1 week post-training (9 weeks later)

  2. Frailty

    Physical Frailty Phenotype, reported on a scale of 0-5. A higher score indicates increased frailty.

    Time frame: Baseline (Day 0) and 1 week post-training (9 weeks later)

  3. Self-reported Assessment: Enjoyment

    Participant report of enjoyment, usability, and feasibility of the exercise program (1-5 scale), where higher scores indicate increased self-report.

    Time frame: At study completion, or on average 1 week post-training

  4. SF-36

    Short-form health survey to evaluate participant self-reported health quality of life.

    Time frame: Baseline (Day 0) and 1 week post-training (9 weeks later)

  5. STEADI

    Self-report (0 to 14-point scale), where increased scores indicate increased fall risk.

    Time frame: Baseline (Day 0) and 1 week post-training (9 weeks later)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — No identifying information will be shared.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Dec 2026, 9 months after the start.

Of 184 non-industry interventional studies with no phase under Gait Disorders, Neurologic, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 38. This study's planned 9 months is below that.

Counting every sponsor, half of 197 studies reached it within 14 months; a quarter within 5 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 15, 2026
First posted
Feb 25, 2026
StartActual
Feb 16, 2026
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Aug 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07433153
Lead sponsor
Binghamton University
Responsible party
Vipul Lugade (Associate Professor, Binghamton University) — Principal investigator
First posted
Feb 25, 2026
Start date
Feb 16, 2026
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Aug 25, 2026

Study contacts

Vipul Lugade, PhD
Contact
vlugade@binghamton.edu
16077774700
Patima Silsupadol, PT, PhD
Contact
patimas@binghamton.edu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion